Prenatal Whole-Genome Sequencing for Fetal Anomalies: Diagnostic Performance, Challenges, and Clinical Implications
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27083568 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Threebhorn Kamlungkuea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Prenatal Diagnosis, Congenital Abnormalities, Fetus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prenatal whole-genome sequencing (WGS) is a comprehensive genetic test for fetal anomalies, enabling simultaneous detection of aneuploidies, copy number variants (CNVs), single-nucleotide variants (SNVs), small insertions/deletions, structural variants, and regions of absence of heterozygosity. However, its clinical performance, optimal sequencing strategies, and implementation challenges remain incompletely defined. We conducted a narrative review of PubMed-indexed studies (1966–December 2025) evaluating prenatal WGS in fetuses with structural anomalies. Across 29 studies, diagnostic yield ranged from approximately 20% to 40%, influenced by phenotype complexity, sequencing depth, and study design. Low-coverage WGS (≤5×) reliably detected large chromosomal abnormalities with a performance comparable to chromosomal microarray analysis. Moderate-coverage WGS (20–40×) additionally enabled detection of SNVs and structural variants, providing up to 30% incremental diagnostic yield after uninformative standard testing. Turnaround times were typically 14–21 days. Higher sequencing depth increases detection of variants of uncertain significance (0.6% to 35.7%) and secondary/incidental findings (1.6–30.8%). Prenatal WGS offers meaningful diagnostic value but requires careful patient selection, multidisciplinary expertise, and structured pre- and post-test genetic counseling to ensure responsible integration into routine clinical practice, with careful consideration of clinical benefit and economic feasibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fetal Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
ORCID-Profile: Threebhorn Kamlungkuea, Kuntharee Traisrisilp, Suchaya Luewan, Jeerawan Klangjorhor, Duangrurdee Wattanasirichaigoon, Fuanglada Tongprasert
Zitieren
APA
Kamlungkuea, T., Traisrisilp, K., Luewan, S., Klangjorhor, J., Wattanasirichaigoon, D., & Tongprasert, F. (2026). Prenatal Whole-Genome Sequencing for Fetal Anomalies: Diagnostic Performance, Challenges, and Clinical Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27083568
Vancouver
Kamlungkuea T, Traisrisilp K, Luewan S, Klangjorhor J, Wattanasirichaigoon D, Tongprasert F. Prenatal Whole-Genome Sequencing for Fetal Anomalies: Diagnostic Performance, Challenges, and Clinical Implications. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27083568
BibTeX
@article{Kamlungkuea2026,
author = {Kamlungkuea, Threebhorn and Traisrisilp, Kuntharee and Luewan, Suchaya and Klangjorhor, Jeerawan and Wattanasirichaigoon, Duangrurdee and Tongprasert, Fuanglada},
title = {Prenatal Whole-Genome Sequencing for Fetal Anomalies: Diagnostic Performance, Challenges, and Clinical Implications},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27083568}
}
EUVIMED